(Q36403814)

14 August 2017

Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity (English)

1 reference

14 August 2017

1 reference

1 reference

1 reference

mumps virus

1 reference

1 reference

Christian J Sauder

1

1 reference

14 August 2017

Kari M Vandenburgh

2

1 reference

14 August 2017

Rebecca C Iskow

3

1 reference

14 August 2017

Tahir Malik

4

1 reference

14 August 2017

Kathryn M Carbone

5

1 reference

14 August 2017

Steven A Rubin

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

21 February 2006

1 reference

14 August 2017

1 reference

14 August 2017

350

1 reference

14 August 2017

1

1 reference

14 August 2017

48-57

1 reference

Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Paraná, Brazil, 1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Acute bilateral total deafness complicating mumps.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Genetic studies on a mumps vaccine strain associated with meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Central nervous system involvement during mumps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Basic concepts in RNA virus evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Strain-variable editing during transcription of the P gene of mumps virus may lead to the generation of non-structural proteins NS1 (V) and NS2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Safety of live mumps virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Amino acid changes responsible for attenuation of virus neurovirulence in an infectious cDNA clone of the Oshima strain of tick-borne encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Mumps-induced opsoclonus-myoclonus and ataxia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Clinical appearance and outcome in mumps encephalitis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Six-helix bundle assembly and analysis of the central core of mumps virus fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Accumulation of terminally deleted RNAs may play a role in Seoul virus persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Current Status of Mumps in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps virus Urabe vaccine strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Structure and function of a paramyxovirus fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Transverse myelitis following mumps in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Vaccinoprophylaxis of mumps using mumps vaccine, strain Sofia 6, in Bulgaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Loss of N-linked glycosylation from the hemagglutinin-neuraminidase protein alters virulence of Newcastle disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Conservation of coding potential and terminal sequences in four different isolates of Borna disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Functional characterization of the genomic promoter of borna disease virus (BDV): implications of 3'-terminal sequence heterogeneity for BDV persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Genome trimming: a unique strategy for replication control employed by Borna disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Canine distemper virus L gene: sequence and comparison with related viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Rapid method for the characterization of 3' and 5' UTRs of influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Aqueductal stenosis and hydrocephalus after mumps encephalitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Transverse myelitis following mumps in an adult -- a case report with MRI correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Cloning and sequencing of the mumps virus fusion protein gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidasegene in wild-type strains of mumps virus is the most relevant marker of virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

7 January 2021

Hydrocephalus due to acute aqueductal stenosis following mumps infection: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

7 January 2021

Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

7 January 2021

Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.035

7 January 2021

10.1016/J.VIROL.2006.01.035

Identifiers

DOI

1 reference

14 August 2017

1 reference